We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Accrol Group Holdings Plc | LSE:ACRL | London | Ordinary Share | GB00BZ6VT592 | ORD GBP0.001 |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.25 | -0.65% | 38.20 | 38.00 | 38.40 | 38.50 | 38.20 | 38.20 | 3,036,351 | 16:29:27 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Convrt Paper,paperbd Pds,nec | 241.91M | -5.7M | -0.0179 | -21.34 | 121.81M |
TIDMACRL
RNS Number : 4967K
Accrol Group Holdings PLC
10 July 2017
10 July 2017
Accrol Group Holdings plc
Appointment of Joint Corporate Broker
Accrol Group Holdings plc, the AIM listed leading independent tissue converter, is pleased to announce the appointment of Liberum Capital Limited as its joint corporate broker alongside Zeus Capital Limited, the Group's NOMAD and corporate broker, with immediate effect.
For further information please contact: Zeus Capital Limited (Nominated Adviser & Joint Broker) Dan Bate / Jonathan Sharp Tel: +44 (0) 161 831 1512 Dominic King / Mike Seabrook Tel: +44 (0) 20 3829 / John Goold 5000 Liberum Capital Limited (Joint Broker) Clayton Bush / Chris Clarke Tel: +44 (0) 020 3100 / Lucy Sharma / Dominik 2222 Götzenberger Camarco (Media enquiries) Jennifer Renwick / Kimberley Tel: +44 (0) 203 757 Taylor 4994
This information is provided by RNS
The company news service from the London Stock Exchange
END
APPZDLFBDDFLBBK
(END) Dow Jones Newswires
July 10, 2017 02:01 ET (06:01 GMT)
1 Year Accrol Chart |
1 Month Accrol Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions